PCIBo — PCI Biotech Holding ASA Share News
0.000.00%
- NOK6.07m
- -NOK7.27m
- NOK6.74m
Brief: PCI Biotech Holding ASA Decided To Stop Release Study
Brief: PCI Biotech And MDimune Announce Research Collaboration Agreement
Brief: PCI Biotech Says Independent Data Monitoring Committee Recommends Continuation Of Two Treatments In Release Trial
Brief: PCI Biotech Provides Update On Regulatory Interactions For RELEASE Trial
Brief: PCI Biotech Q3 Oper Result Loss Flat At Nok 22.5 Mln
Brief: PCI Biotech Q2 Operating Loss Narrows To NOK 19.1 Mln
Brief: PCI Biotech Granted New US Patent
Brief: PCI Biotech Gets Orphan Drug Designation In South Korea
Brief: PCI Biotech Holding Q1 Operating Loss Widens To NOK 21.2 Mln
Brief: PCI Biotech Holding Q4 Operating Loss Narrows To NOK 21.4 Mln
Brief: PCI Biotech: Successful Phase I fimaVacc Vaccination Proof Of Concept Study To Be Published In Frontiers In Immunology
Brief: PCI Biotech Granted New European Patent
Brief: PCI Biotech Holding: AstraZeneca Not To Enter Into Definitive Agreement For FimaNAc Technology
Brief: PCI Biotech Announces Collaboration With DCprime
Brief: PCI Biotech Q2 Net Result Swings To Loss Of NOK 6.7 Mln
Brief: PCI Biotech Gives Update On Preclinical Research Collaboration Agreement With Astrazeneca
Brief: PCI Biotech Q1 Net Financial Result Swings To Profit Of NOK 20.4 Million
Brief: PCI Biotech: US Patent For The Vaccine Technology To Be Granted In April
Brief: PCI Biotech Updates On Operational Implications Of The Corona Pandemic